Ianthus Stock Price, News & Analysis

iAnthus Capital Holdings (OTCQB: ITHUF) has released its financial results for Q4 and full year 2024. The company reported annual revenue of $167.6 million, marking a 5.2% increase from the previous year, with a gross profit of $75.1 million (up 18.9%). The gross margin improved by 516 basis points to 45%.

For Q4 2024, revenue reached $42.7 million, showing sequential growth of $2.4 million from Q3 and a year-over-year increase of $1.8 million. The quarter's gross profit was $19.1 million, with a 45% gross margin. Notable improvements include reduced net losses, with annual net loss decreasing to $7.6 million from $76.6 million in 2023. The company's Adjusted EBITDA for 2024 reached $23.9 million, a significant increase of $15.6 million from the prior year.

iAnthus Capital Holdings (CSE: IAN, OTCQB: ITHUF) has opened its first GrowHealthy dispensary in Jacksonville, Florida, marking its 21st location statewide. The new facility, located at 12041 Beach Blvd., features innovative patient-centric elements including tethered bud displays and magnifying glasses for trichome inspection.

The grand opening on February 21, 2025, attracted strong patient turnout. The dispensary's design allows customers to examine products independently, enhancing the shopping experience. According to CEO Richard Proud, this expansion aligns with the company's 'smart growth' and 'strong margins' strategy in the Florida market, where nearly one million residents use medical cannabis for conditions like chronic pain and sleep disturbances.

iAnthus Capital Holdings (ITHUF) has announced the sale of select Arizona assets to Sonoran Roots for $36.5 million. The transaction includes three dispensaries and two processing/cultivation facilities, with iAnthus retaining one dispensary in Mesa, Arizona.

The purchase price consists of $20 million in cash payable at closing and a $16.5 million secured promissory note bearing 6% annual interest over 66 months. The deal, expected to close in 1Q2025, aligns with iAnthus' strategy to optimize its portfolio and focus on key growth markets including Florida, Maryland, New Jersey, Massachusetts, and New York.

The proceeds will be used for working capital, general corporate purposes, and partial repayment of secured debt obligations. iAnthus will maintain its presence in Arizona through its Health for Life dispensary in Crismon and the MPX brand.

iAnthus Capital Holdings (CSE: IAN, OTCQB: ITHUF) has appointed Justin Vu as permanent Chief Financial Officer, effective immediately. Vu, who previously served as Interim CFO since April 5, 2024, joined the company in early 2023 as Senior Vice President of Finance. Before iAnthus, he worked as a financial consultant and held senior finance and accounting positions at a major US media and entertainment company.

CEO Richard Proud expressed confidence in Vu's appointment, citing his demonstrated track record in execution, operational efficiency, and driving results since joining the cannabis operations company.

iAnthus Capital Holdings (ITHUF) has announced the acquisition of Cheetah vape brand through an asset purchase agreement. The transaction includes Cheetah's cannabis wholesale business in Illinois and Pennsylvania, with plans for expansion throughout 2025. The purchase price comprises US$1.5 million in common shares issued in three tranches at US$0.012 per share, plus performance-based cash payments until April 2028.

As part of the deal, Cheetah's Co-Founder and CEO Michael Piermont will join iAnthus as Chief Commercial Officer. The acquisition aims to strengthen iAnthus' brand portfolio and market presence, particularly in the premium live resin vape products segment. The companies plan to leverage shared resources and operational efficiencies to pursue national growth opportunities.

iAnthus Capital Holdings (CSE: IAN, OTCQB: ITHUF) has reached a settlement agreement on December 3, 2024, regarding litigation with Ninth Square Capital The settlement resolves consolidated claims filed in August 2019 concerning alleged oppressive conduct related to an arrangement between iAnthus and MPX Bioceutical

Under the settlement terms, iAnthus will issue 5,000,000 common shares to Ninth Square at a deemed price of C$0.01 per share. The company maintains no admission of wrongdoing or liability and continues to contest the allegations. The shares will be issued under Canadian securities laws with no hold period and through U.S. Securities Act exemptions.

iAnthus Capital Holdings reported its Q3 2024 financial results, showing mixed performance. Revenue decreased to $40.3 million, down 6.3% from Q2 2024 and 6.1% year-over-year. Gross profit reached $18.1 million with a margin of 44.9%, showing a quarterly decline but yearly improvement. The company reported a net loss of $11.6 million, wider than Q2's $9.8 million loss. Adjusted EBITDA was $5.3 million, decreasing from $8.9 million in Q2 2024 but improving from $0.8 million in Q3 2023.

iAnthus Capital Holdings, Inc. (CSE: IAN) (OTCQB: ITHUF) reported its Q2 2024 financial results. Key highlights include:

• Revenue of $43.0 million, up 3.5% from Q1 2024 and 11.1% year-over-year
• Gross profit of $20.7 million, a 20.3% increase from Q1 2024
• Gross margin of 48.1%, up 673bps from Q1 2024
• Net loss of $9.8 million, improved from $14.0 million in Q1 2024
• Adjusted EBITDA of $8.9 million, up from $3.2 million in Q1 2024

The company showed sequential improvements in key financial metrics, indicating positive momentum in its operations across regulated cannabis markets in the United States.

iAnthus Capital Holdings announced the results of their Annual General and Special Meeting of Shareholders held on June 27, 2024. Key resolutions put forward were approved, including the election of Scott Cohen, Michelle Mathews-Spradlin, Kenneth W. Gilbert, Alexander Shoghi, and Richard Proud as directors. Additionally, PKF O'Connor Davies, LLP was appointed as the company's auditors, and the amended and restated Omnibus Incentive Plan received shareholder approval.